Clin2
NCT07018544Likely a fitEnrolling by invitation

Wegovy safety and effectiveness study in Korea

Obesity and Overweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This study watches how Wegovy (semaglutide) works and its side effects when given by doctors to patients with obesity or overweight in South Korea. It is not testing a new drug, but collecting information from routine care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
840 people
Ages
19 years and older
Study type
Observational

Who can take part

  • You are an adult aged 19 or older.
  • You have obesity or are overweight and your doctor has decided to prescribe Wegovy for you.
  • You have not taken Wegovy or any semaglutide medicine before.
  • You are not allergic to semaglutide or any of its ingredients.
  • If you could become pregnant, you are using effective birth control and are not pregnant or breastfeeding.
  • You are able to understand and cooperate with the study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07280221Enrolling by invitation
Wegovy real-world weight loss study in Korea

This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.

Goyang-si, Gyeonggi-do
NCT07055607Enrolling by invitation
Real-world study of Wegovy for weight management

This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.

Barcelona
NCT07036172Recruiting· Phase 3
Semaglutide vs Wegovy for weight loss in Chinese adults

This trial compares a semaglutide injection to the already-approved weight loss drug Wegovy in Chinese adults with obesity. It aims to see if the new option works just as well to help people lose weight.

Beijing
NCT07430059Not yet recruiting· Phase 1
Study of a semaglutide implant for weight management

This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.

NCT06633783Not yet recruiting· Phase 3
Weekly shot for weight loss in adults with obesity

This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.

Xuancheng, Anhui
NCT07779343Recruiting
Multidisciplinary support for adults living with obesity

This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.

Algiers

Hear when a new Obesity and Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.